Walker & Dunlop Reports Mixed Q4 2025 Results Amid Strategic Shifts — Walker & Dunlop, Inc.

Event summary

Walker & Dunlop reported a 36% increase in total transaction volume to $18.3 billion YoY, but a diluted loss per share of $0.41 in Q4 2025.
Adjusted EBITDA decreased by 59% YoY to $38.8 million, impacted by $66.2 million in impairment charges and loan repurchase expenses.
The company declared a $0.68 per share dividend for Q1 2026, a 1.5% increase over 2025.
Walker & Dunlop maintained top rankings as the #1 Fannie Mae DUS lender and #3 Freddie Mac Optigo lender.
The company ended 2025 with $299 million in cash and cash equivalents.

The big picture

Walker & Dunlop's Q4 2025 results reflect a mixed performance, with strong transaction volume growth offset by significant impairment charges and loan repurchase expenses. The company's strategic focus on becoming the leading commercial real estate capital markets firm will be tested by its ability to navigate regulatory challenges and sustain its market share in an improving commercial real estate transaction market. The $144 billion servicing portfolio and robust Capital Markets pipeline position the company for potential growth in 2026 and beyond.

What we're watching

Execution Risk: Whether Walker & Dunlop can sustain its momentum in the Capital Markets business amid regulatory and market challenges.
Regulatory Headwinds: The impact of potential GSE reforms and borrower fraud investigations on the company's loan repurchase obligations.
Strategic Shifts: The pace at which Walker & Dunlop can divest underperforming assets and reposition its portfolio for growth.